{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T13:19:51Z","timestamp":1794057591221,"version":"4.8.0"},"reference-count":109,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","license":[{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,26]]},"abstract":"<jats:p>Sepsis is caused by the body\u2019s dysregulated response to infection, which can lead to multiorgan injury and death. Patients with sepsis may develop acute cardiac dysfunction, termed septic cardiomyopathy, which is a global but reversible dysfunction of both sides of the heart. This narrative review discusses the mechanistic changes in the heart during septic cardiomyopathy, its diagnosis, existing treatment options regarding severity and course, and emerging treatment approaches. Although no standardized definition for septic cardiomyopathy exists, it is described as a reversible myocardial dysfunction that typically resolves within 7 to 10 days. Septic cardiomyopathy is often diagnosed based on electrocardiography, cardiac magnetic resonance imaging, biomarkers, and direct invasive and noninvasive measures of cardiac output. Presently, the treatment of septic cardiomyopathy is similar to that of sepsis, primarily focusing on acute interventions. Treatments for cardiomyopathy often include angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and diuretics. However, because of profound hypotension in sepsis, many cardiomyopathy treatments are contraindicated in patients with septic cardiomyopathy. Substantial efforts have been made to study the pathophysiological mechanisms and diagnostic options; however, the lack of a uniform definition for septic cardiomyopathy is challenging for physicians when considering treatments. Another challenge for physicians is that the treatment for septic cardiomyopathy has only focused on acute intervention, whereas the treatment for other cardiomyopathies has been provided on a long-term basis. A better understanding of the underlying mechanisms of septic cardiomyopathy may contribute to the development of a unified definition of the condition and novel treatment options.<\/jats:p>","DOI":"10.1097\/md.0000000000037940","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T14:03:18Z","timestamp":1714140198000},"page":"e37940","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":44,"title":["Clinical implications of septic cardiomyopathy: A narrative review"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1606-7037","authenticated-orcid":false,"given":"Hiroaki","family":"Hiraiwa","sequence":"first","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8692-3003","authenticated-orcid":false,"given":"Daisuke","family":"Kasugai","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5076-2052","authenticated-orcid":false,"given":"Takahiro","family":"Okumura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2723-6243","authenticated-orcid":false,"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41569-020-00492-2","article-title":"Pathophysiology of sepsis-induced cardiomyopathy.","volume":"18","author":"Hollenberg","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/CCM.0000000000002851","article-title":"Septic cardiomyopathy.","volume":"46","author":"Beesley","year":"2018","journal-title":"Crit Care Med"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"9452","DOI":"10.12998\/wjcc.v9.i31.9452","article-title":"Incidence, prognosis, and risk factors of sepsis-induced cardiomyopathy.","volume":"9","author":"Liang","year":"2021","journal-title":"World J Clin Cases"},{"key":"R6-20250503","first-page":"640","article-title":"Cardiomyopathy: an overview.","volume":"96","author":"Brieler","year":"2017","journal-title":"Am Fam Physician"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"483","DOI":"10.7326\/0003-4819-100-4-483","article-title":"Profound but reversible myocardial depression in patients with septic shock.","volume":"100","author":"Parker","year":"1984","journal-title":"Ann Intern Med"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.chest.2018.08.1037","article-title":"The septic heart: current understanding of molecular mechanisms and clinical implications.","volume":"155","author":"Martin","year":"2019","journal-title":"Chest"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11886-020-01277-2","article-title":"Sepsis-induced cardiomyopathy: a comprehensive review.","volume":"22","author":"L\u2019Heureux","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13071-020-04104-3","article-title":"Therapeutic efficacy of Schistosoma japonicum cystatin on sepsis-induced cardiomyopathy in a mouse model.","volume":"13","author":"Gao","year":"2020","journal-title":"Parasit Vectors"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.chest.2020.12.016","article-title":"Impact of right ventricular dysfunction on short-term and long-term mortality in sepsis: a meta-analysis of 1,373 patients.","volume":"159","author":"Vallabhajosyula","year":"2021","journal-title":"Chest"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"100767","DOI":"10.1016\/j.cpcardiol.2020.100767","article-title":"Septic cardiomyopathy: from basics to management choices.","volume":"46","author":"Ravikumar","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40560-015-0112-5","article-title":"A review of sepsis-induced cardiomyopathy.","volume":"3","author":"Sato","year":"2015","journal-title":"J Intensive Care"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jcp.30527","article-title":"Pathogenetic mechanisms of septic cardiomyopathy.","volume":"237","author":"Wang","year":"2022","journal-title":"J Cell Physiol"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1172\/JCI112135","article-title":"A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance.","volume":"76","author":"Parrillo","year":"1985","journal-title":"J Clin Invest"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40560-016-0148-1","article-title":"Sepsis-induced myocardial dysfunction: pathophysiology and management.","volume":"4","author":"Kakihana","year":"2016","journal-title":"J Intensive Care"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/AIA.0b013e3182603ec1","article-title":"Septic cardiomyopathy.","volume":"50","author":"Phillips","year":"2012","journal-title":"Int Anesthesiol Clin"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"802085","DOI":"10.3389\/fimmu.2021.802085","article-title":"Roles of LncRNAs in regulating mitochondrial dysfunction in septic cardiomyopathy.","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1084\/jem.183.3.949","article-title":"Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum.","volume":"183","author":"Kumar","year":"1996","journal-title":"J Exp Med"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1126\/science.1631560","article-title":"Negative inotropic effects of cytokines on the heart mediated by nitric oxide.","volume":"257","author":"Finkel","year":"1992","journal-title":"Science"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s15010-020-01424-5","article-title":"First case of COVID-19 complicated with fulminant myocarditis: a case report and insights.","volume":"48","author":"Zeng","year":"2020","journal-title":"Infection"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s42269-019-0227-2","article-title":"Toll-like receptors activation, signaling, and targeting: an overview.","volume":"43","author":"El-Zayat","year":"2019","journal-title":"Bull Natl Res Cent"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3389\/fimmu.2017.00719","article-title":"Toll-like receptor 4 inhibition improves oxidative stress and mitochondrial health in isoproterenol-induced cardiac hypertrophy in rats.","volume":"8","author":"Katare","year":"2017","journal-title":"Front Immunol"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"653601","DOI":"10.3389\/fphys.2021.653601","article-title":"Hydrogen sulfide attenuated sepsis-induced myocardial dysfunction through tlr4 pathway and endoplasmic reticulum stress.","volume":"12","author":"Chen","year":"2021","journal-title":"Front Physiol"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1002\/ctm2.266","article-title":"Activation of Toll-like receptor 7 provides cardioprotection in septic cardiomyopathy-induced systolic dysfunction.","volume":"11","author":"Saiyang","year":"2021","journal-title":"Clin Transl Med"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1084\/jem.20051207","article-title":"An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.","volume":"203","author":"Niederbichler","year":"2006","journal-title":"J Exp Med"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1096\/fj.11-183236","article-title":"Complement dependency of cardiomyocyte release of mediators during sepsis.","volume":"25","author":"Atefi","year":"2011","journal-title":"FASEB J"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molimm.2016.11.012","article-title":"Complement and sepsis-induced heart dysfunction.","volume":"84","author":"Fattahi","year":"2017","journal-title":"Mol Immunol"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.CIR.96.7.2414","article-title":"Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction.","volume":"96","author":"Hill","year":"1997","journal-title":"Circulation"},{"key":"R30-20250503","first-page":"146","article-title":"Reduction in oxidative stress and modulation of heart failure subsequent to myocardial infarction in rats.","volume":"10","author":"Hill","year":"2005","journal-title":"Exp Clin Cardiol"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease.","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol Rev"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"R474","DOI":"10.1186\/cc2969","article-title":"Effects of lornoxicam on the physiology of severe sepsis.","volume":"8","author":"Memis","year":"2004","journal-title":"Crit Care"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"319.e9","DOI":"10.1016\/j.jcrc.2011.06.017","article-title":"Ventricular dysfunction and dilation in severe sepsis and septic shock: relation to endothelial function and mortality.","volume":"27","author":"Furian","year":"2012","journal-title":"J Crit Care"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(02)09459-X","article-title":"Association between mitochondrial dysfunction and severity and outcome of septic shock.","volume":"360","author":"Brealey","year":"2002","journal-title":"Lancet"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2174\/1381612825666190708155400","article-title":"Mitochondrial injury and targeted intervention in septic cardiomyopathy.","volume":"25","author":"Tan","year":"2019","journal-title":"Curr Pharm Des"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00018-015-2052-6","article-title":"The endoplasmic reticulum: structure, function and response to cellular signaling.","volume":"73","author":"Schwarz","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"101287","DOI":"10.1016\/j.redox.2019.101287","article-title":"Therapeutic contribution of melatonin to the treatment of septic cardiomyopathy: a novel mechanism linking Ripk3-modified mitochondrial performance and endoplasmic reticulum function.","volume":"26","author":"Zhong","year":"2019","journal-title":"Redox Biol"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1002\/jcp.29190","article-title":"Melatonin attenuates ER stress and mitochondrial damage in septic cardiomyopathy: a new mechanism involving BAP31 upregulation and MAPK-ERK pathway.","volume":"235","author":"Zhang","year":"2020","journal-title":"J Cell Physiol"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13054-018-2043-8","article-title":"Pathophysiology, echocardiographic evaluation, biomarker findings, and prognostic implications of septic cardiomyopathy: a review of the literature.","volume":"22","author":"Ehrman","year":"2018","journal-title":"Crit Care"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"18823","DOI":"10.1038\/s41598-021-98397-8","article-title":"Clinical impact of visually assessed right ventricular dysfunction in patients with septic shock.","volume":"11","author":"Hiraiwa","year":"2021","journal-title":"Sci Rep"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.3390\/cells11182833","article-title":"Septic cardiomyopathy: from pathophysiology to the clinical setting.","volume":"11","author":"Carbone","year":"2022","journal-title":"Cells"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.amjcard.2018.05.040","article-title":"Evolving concepts in diagnosis and management of cardiogenic shock.","volume":"122","author":"Bellumkonda","year":"2018","journal-title":"Am J Cardiol"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00134-017-4698-z","article-title":"Left ventricular systolic dysfunction during septic shock: the role of loading conditions.","volume":"43","author":"Boissier","year":"2017","journal-title":"Intensive Care Med"},{"key":"R44-20250503","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/ehf2.13938","article-title":"Characterization of critically ill patients with septic shock and sepsis-associated cardiomyopathy using cardiovascular MRI.","volume":"9","author":"Muehlberg","year":"2022","journal-title":"ESC Heart Fail"},{"key":"R45-20250503","doi-asserted-by":"crossref","first-page":"e011991","DOI":"10.1161\/JAHA.119.011991","article-title":"Cardiogenic shock.","volume":"8","author":"Vahdatpour","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"R46-20250503","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/SHK.0000000000001395","article-title":"Myocardial edema: an overlooked mechanism of septic cardiomyopathy?","volume":"53","author":"Vasques-Novoa","year":"2020","journal-title":"Shock"},{"key":"R47-20250503","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fphar.2020.00210","article-title":"Current status of septic cardiomyopathy: basic science and clinical progress.","volume":"11","author":"Lin","year":"2020","journal-title":"Front Pharmacol"},{"key":"R48-20250503","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.chest.2020.09.274","article-title":"Right ventricular dysfunction in early sepsis and septic shock.","volume":"159","author":"Lanspa","year":"2021","journal-title":"Chest"},{"key":"R49-20250503","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jcrc.2014.03.007","article-title":"Correlation of left ventricular systolic dysfunction determined by low ejection fraction and 30-day mortality in patients with severe sepsis and septic shock: a systematic review and meta-analysis.","volume":"29","author":"Sevilla Berrios","year":"2014","journal-title":"J Crit Care"},{"key":"R50-20250503","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"R51-20250503","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.3390\/jpm12111786","article-title":"The role of left ventricular ejection fraction and left ventricular outflow tract velocity-time integral in assessing cardiovascular impairment in septic shock.","volume":"12","author":"Spathoulas","year":"2022","journal-title":"J Pers Med"},{"key":"R52-20250503","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13054-022-04095-w","article-title":"Feasibility and discriminatory value of tissue motion annular displacement in sepsis-induced cardiomyopathy: a single-center retrospective observational study.","volume":"26","author":"Song","year":"2022","journal-title":"Crit Care"},{"key":"R53-20250503","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13054-016-1327-0","article-title":"Speckle tracking echocardiography in patients with septic shock: a case control study (SPECKSS).","volume":"20","author":"Ng","year":"2016","journal-title":"Crit Care"},{"key":"R54-20250503","first-page":"6098654","article-title":"Subclinical left ventricular systolic dysfunction in patients with septic shock based on sepsis-3 definition: a speckle-tracking echocardiography study.","volume":"2020","author":"Hai","year":"2020","journal-title":"Crit Care Res Pract"},{"key":"R55-20250503","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1136\/heartjnl-2020-316889","article-title":"Association between right ventricle dysfunction and poor outcome in patients with septic shock.","volume":"106","author":"Kim","year":"2020","journal-title":"Heart"},{"key":"R56-20250503","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1540-8175.2007.00510.x","article-title":"Right ventricular function assessment: comparison of geometric and visual method to short-axis slice summation method.","volume":"24","author":"Drake","year":"2007","journal-title":"Echocardiogr"},{"key":"R57-20250503","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s10554-019-01653-2","article-title":"Visual assessment of right ventricular function by echocardiography: how good are we?","volume":"35","author":"Schneider","year":"2019","journal-title":"Int J Cardiovasc Imaging"},{"key":"R58-20250503","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40560-016-0159-y","article-title":"Right heart in septic shock: prospective observational study.","volume":"4","author":"Singh","year":"2016","journal-title":"J Intensive Care"},{"key":"R59-20250503","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40560-021-00549-5","article-title":"Afterload-related cardiac performance identifies cardiac impairment and associates with outcome in patients with septic shock: a retrospective cohort study.","volume":"9","author":"Chen","year":"2021","journal-title":"J Intensive Care"},{"key":"R60-20250503","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00392-011-0292-5","article-title":"Septic cardiomyopathy: hemodynamic quantification, occurrence, and prognostic implications.","volume":"100","author":"Werdan","year":"2011","journal-title":"Clin Res Cardiol"},{"key":"R61-20250503","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-013-2902-3","article-title":"Prognostic value of troponins in sepsis: a meta-analysis.","volume":"39","author":"Bessiere","year":"2013","journal-title":"Intensive Care Med"},{"key":"R62-20250503","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/cc13864","article-title":"New insights into the mechanisms involved in B-type natriuretic peptide elevation and its prognostic value in septic patients.","volume":"18","author":"Papanikolaou","year":"2014","journal-title":"Crit Care"},{"key":"R63-20250503","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1097\/CCM.0000000000001162","article-title":"Circulating histones are major mediators of cardiac injury in patients with sepsis.","volume":"43","author":"Alhamdi","year":"2015","journal-title":"Crit Care Med"},{"key":"R64-20250503","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF03194597","article-title":"The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism.","volume":"47","author":"Chmurzynska","year":"2006","journal-title":"J Appl Genet"},{"key":"R65-20250503","doi-asserted-by":"crossref","first-page":"415.e13","DOI":"10.1016\/j.jcrc.2012.01.004","article-title":"Usefulness of heart-type fatty acid-binding protein in patients with severe sepsis.","volume":"27","author":"Zhang","year":"2012","journal-title":"J Crit Care"},{"key":"R66-20250503","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/CCM.0000000000003560","article-title":"Risk factors for new-onset atrial fibrillation in patients with sepsis: a systematic review and meta-analysis.","volume":"47","author":"Bosch","year":"2019","journal-title":"Crit Care Med"},{"key":"R67-20250503","first-page":"CD003408","article-title":"Pulmonary artery catheters for adult patients in intensive care.","volume":"3","author":"Harvey","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R68-20250503","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/CIRCRESAHA.115.306573","article-title":"Myocarditis.","volume":"118","author":"Fung","year":"2016","journal-title":"Circ Res"},{"key":"R69-20250503","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"key":"R70-20250503","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2169\/internalmedicine.5498-20","article-title":"An autopsy case of fulminant, suppurative bacterial myocarditis caused by Group B Streptococcus.","volume":"61","author":"Nakashima","year":"2022","journal-title":"Intern Med"},{"key":"R71-20250503","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jccase.2022.02.004","article-title":"Recurrent fulminant non-rheumatic streptococcal myocarditis proven by endomyocardial biopsy and autopsy.","volume":"26","author":"Hiraiwa","year":"2022","journal-title":"J Cardiol Cases"},{"key":"R73-20250503","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jcrc.2018.06.001","article-title":"When the heart gets the flu: fulminant influenza B myocarditis: a case-series report and review of the literature.","volume":"47","author":"H\u00e9kimian","year":"2018","journal-title":"J Crit Care"},{"key":"R74-20250503","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ams2.394","article-title":"Influenza-associated septic shock accompanied by septic cardiomyopathy that developed in summer and mimicked fulminant myocarditis.","volume":"6","author":"Fujioka","year":"2019","journal-title":"Acute Med Surg"},{"key":"R75-20250503","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1161\/CIR.0000000000000745","article-title":"Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association.","volume":"141","author":"Kociol","year":"2020","journal-title":"Circulation"},{"key":"R76-20250503","first-page":"137","article-title":"Fulminant myocarditis in adults: a narrative review.","volume":"19","author":"Montero","year":"2022","journal-title":"J Geriatr Cardiol"},{"key":"R77-20250503","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016.","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit Care Med"},{"key":"R78-20250503","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"R79-20250503","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.medin.2017.08.009","article-title":"Levosimendan in patients with cardiogenic shock complicating myocardial infarction: a meta-analysis.","volume":"42","author":"Fang","year":"2018","journal-title":"Med Intensiva (Engl Ed)"},{"key":"R80-20250503","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jointm.2021.11.004","article-title":"Septic cardiomyopathy: diagnosis and management.","volume":"2","author":"Boissier","year":"2021","journal-title":"J Intensive Med"},{"key":"R81-20250503","doi-asserted-by":"crossref","first-page":"100864","DOI":"10.1016\/j.blre.2021.100864","article-title":"Coagulopathy and sepsis: pathophysiology, clinical manifestations and treatment.","volume":"50","author":"Giustozzi","year":"2021","journal-title":"Blood Rev"},{"key":"R82-20250503","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.3390\/jcm11175241","article-title":"Mechanical circulatory support devices for the treatment of cardiogenic shock complicating acute myocardial infarction-a review.","volume":"11","author":"Bruoha","year":"2022","journal-title":"J Clin Med"},{"key":"R83-20250503","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1053\/j.jvca.2022.04.025","article-title":"Sepsis-induced cardiomyopathy reviewed: the case for early consideration of mechanical support.","volume":"36","author":"Plack","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R84-20250503","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1097\/MJT.0000000000000272","article-title":"Impact of dobutamine in patients with septic shock: a meta-regression analysis.","volume":"24","author":"Nadeem","year":"2017","journal-title":"Am J Ther"},{"key":"R85-20250503","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00134-013-2982-0","article-title":"Effects of dobutamine on systemic, regional and microcirculatory perfusion parameters in septic shock: a randomized, placebo-controlled, double-blind, crossover study.","volume":"39","author":"Hernandez","year":"2013","journal-title":"Intensive Care Med"},{"key":"R86-20250503","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.2013.278477","article-title":"Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.","volume":"310","author":"Morelli","year":"2013","journal-title":"JAMA"},{"key":"R87-20250503","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1536\/ihj.19-420","article-title":"Successful combination of landiolol and levosimendan in patients with decompensated heart failure.","volume":"61","author":"Dabrowski","year":"2020","journal-title":"Int Heart J"},{"key":"R88-20250503","doi-asserted-by":"crossref","first-page":"7722","DOI":"10.3390\/ijms22147722","article-title":"Cardiomyopathies: an overview.","volume":"22","author":"Ciarambino","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R89-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2023.04.019","article-title":"Angiotensin-neprilysin inhibition in patients with mildly reduced or preserved ejection fraction and worsening heart failure.","volume":"82","author":"Mentz","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R90-20250503","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"issue":"8 Pt 1","key":"R91-20250503","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jchf.2023.03.017","article-title":"Beta-blocker use and heart failure outcomes in mildly reduced and preserved ejection fraction.","volume":"11","author":"Arnold","year":"2023","journal-title":"JACC Heart Fail"},{"key":"R92-20250503","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12872-016-0425-x","article-title":"Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis.","volume":"16","author":"Berbenetz","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"R93-20250503","doi-asserted-by":"crossref","first-page":"911578","DOI":"10.3389\/fcvm.2022.911578","article-title":"Non-invasive assessment of acute heart failure by Stevenson classification: does echocardiographic examination recognize different phenotypes?","volume":"9","author":"Palazzuoli","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R94-20250503","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.mayocp.2012.01.018","article-title":"Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock.","volume":"87","author":"Pulido","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"R95-20250503","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1186\/cc6976","article-title":"Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression.","volume":"12","author":"Schmittinger","year":"2008","journal-title":"Crit Care"},{"key":"R96-20250503","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1378\/chest.109.5.1302","article-title":"Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study.","volume":"109","author":"Barton","year":"1996","journal-title":"Chest"},{"key":"R97-20250503","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/MCC.0000000000000627","article-title":"Venoarterial extracorporeal membrane oxygenation in cardiogenic shock: indications, mode of operation, and current evidence.","volume":"25","author":"Pineton de Chambrun","year":"2019","journal-title":"Curr Opin Crit Care"},{"key":"R98-20250503","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4274\/balkanmedj.galenos.2023.2023-4-6","article-title":"Sepsis-induced coagulopathy subphenotype identification by latent class analysis.","volume":"40","author":"Cai","year":"2023","journal-title":"Balkan Med J"},{"key":"R99-20250503","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.21037\/jtd.2016.12.10","article-title":"Glucose-insulin-potassium correlates with hemodynamic improvement in patients with septic myocardial dysfunction.","volume":"8","author":"Kim","year":"2016","journal-title":"J Thorac Dis"},{"key":"R100-20250503","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00003246-198507000-00012","article-title":"Use of glucose-insulin-potassium (GIK) in human septic shock.","volume":"13","author":"Bronsveld","year":"1985","journal-title":"Crit Care Med"},{"key":"R101-20250503","first-page":"187","article-title":"The heart in sepsis: from basic mechanisms to clinical management.","volume":"11","author":"Rudiger","year":"2013","journal-title":"Curr Vasc Pharmacol"},{"key":"R102-20250503","first-page":"695","article-title":"Insulin in sepsis and septic shock.","volume":"51","author":"Das","year":"2003","journal-title":"J Assoc Physicians India"},{"key":"R103-20250503","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/00000542-200103000-00007","article-title":"Early preload adaptation in septic shock? A transesophageal echocardiographic study.","volume":"94","author":"Vieillard Baron","year":"2001","journal-title":"Anesthesiology"},{"key":"R104-20250503","doi-asserted-by":"crossref","first-page":"120830","DOI":"10.1016\/j.lfs.2022.120830","article-title":"Role of the lectin-like domain of thrombomodulin in septic cardiomyopathy.","volume":"306","author":"Voelker","year":"2022","journal-title":"Life Sci"},{"key":"R105-20250503","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1423-0127-19-34","article-title":"The role of thrombomodulin lectin-like domain in inflammation.","volume":"19","author":"Li","year":"2012","journal-title":"J Biomed Sci"},{"key":"R106-20250503","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.21037\/jtd-22-1309","article-title":"Myocardial protective effect of sivelestat sodium in rat models with sepsis-induced myocarditis.","volume":"14","author":"Zhang","year":"2022","journal-title":"J Thorac Dis"},{"key":"R107-20250503","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40560-021-00555-7","article-title":"The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020).","volume":"9","author":"Egi","year":"2021","journal-title":"J Intensive Care"},{"issue":"1_suppl","key":"R108-20250503","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0267659118766833","article-title":"Veno-arterio-venous ECMO for septic cardiomyopathy: a single-centre experience.","volume":"33","author":"Vogel","year":"2018","journal-title":"Perfusion"},{"key":"R110-20250503","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jemermed.2017.08.093","article-title":"What is the preferred resuscitation fluid for patients with severe sepsis and septic shock?","volume":"53","author":"Winters","year":"2017","journal-title":"J Emerg Med"},{"key":"R111-20250503","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3399\/bjgp17X690401","article-title":"Recognition, diagnosis, and early management of sepsis: NICE guideline.","volume":"67","author":"Tavar\u00e9","year":"2017","journal-title":"Br J Gen Pract"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037940","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T20:39:12Z","timestamp":1746304752000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":109,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037940","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,26]]}}}